Related Experiment Video
Updated: Jun 22, 2025
07:23
Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
252
Noncoding RNAs in tumorigenesis and tumor therapy
Pingping Zhu1,2, Benyu Liu1,3, Zusen Fan1
1CAS Key Laboratory of Infection and Immunity, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China.
Fundamental Research
|June 27, 2024
Summary
Noncoding RNAs (ncRNAs), including long noncoding RNAs (lncRNAs) and circular RNAs (circRNAs), are key regulators in tumorigenesis. These ncRNAs play crucial roles in cancer stem cells and various oncogenic processes, offering potential for tumor diagnosis and therapy.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- Tumorigenesis involves complex interactions, with prior research focusing on protein-coding genes.
- Noncoding RNAs (ncRNAs) are emerging as critical regulators in cancer development.
- This review specifically examines long noncoding RNAs (lncRNAs) and circular RNAs (circRNAs).
Purpose of the Study:
- To review the molecular patterns and roles of ncRNAs in tumorigenesis.
- To highlight the involvement of ncRNAs in cancer stem cells (CSCs), tumor cells, and the tumor microenvironment.
- To discuss the diagnostic and therapeutic potential of ncRNAs in cancer.
Main Methods:
- Literature review focusing on ncRNAs in cancer.
- Analysis of ncRNA involvement in CSC maintenance and oncogenesis.
- Examination of ncRNA roles in key cancer processes like proliferation, apoptosis, metastasis, and immune escape.
Main Results:
- ncRNAs, particularly lncRNAs and circRNAs, are significant modulators in tumorigenesis.
- Dozens of ncRNAs critically regulate cancer stem cells (CSCs) and oncogenesis.
- ncRNAs are implicated in sustaining proliferation, resisting cell death, genome instability, metabolic disorders, immune escape, and metastasis.
Conclusions:
- ncRNA research significantly enhances our understanding of oncogenesis.
- ncRNAs represent promising targets for future cancer diagnosis and therapy.
- Further investigation into ncRNAs will advance cancer treatment strategies.
Related Concept Videos
02:39lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
01:20Types of RNA
5.7K
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
RNA Performs Diverse...
5.7K
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
7.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.4K
01:22MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
01:12Loss of Tumor Suppressor Gene Functions
4.8K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.8K
02:15Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K